Belize vs New Zealand: Treatment success rate for patients treated for MDR-TB
Belize
100.0%
in 2022
New Zealand
100.0%
in 2022
Belize rank
1st
New Zealand rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Belize
- New Zealand
How they compare
Belize currently reports 100.0% against 100.0% in New Zealand, a difference of 0.0%.
The two have swapped places 3 times across 8 shared years of data; in 2009 it was Belize ahead.
Belize ranks 1st and New Zealand ranks 1st of 163 countries.
Across the 3 decades both report, Belize averaged higher in 2 and New Zealand in 1.
Head to head by decade
| Decade | Belize | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 43.0% | 57.0% | Belize |
| 2010s | 87.5% | 83.2% | 4.2% | Belize |
| 2020s | 66.7% | 100.0% | 33.3% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Belize or New Zealand?
- Belize, at 100.0% against 100.0% in New Zealand as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Belize and New Zealand?
- 0.0%, with Belize ahead.
- How many years of comparable data are there for Belize and New Zealand?
- 8 years are reported by both, from 2009 to 2022.
- How do Belize and New Zealand rank globally for treatment success rate for patients treated for mdr-tb?
- Belize ranks 1st and New Zealand ranks 1st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.